🇺🇸 FDA
Patent

US 12173084

Phosphorylated dicer antibody and methods of use thereof

granted A61PA61P35/00

Quick answer

US patent 12173084 (Phosphorylated dicer antibody and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00